Financial reports
10-Q
2016 Q3
Quarterly report
7 Nov 16
10-Q
2016 Q2
Quarterly report
3 Aug 16
10-Q
2016 Q1
Quarterly report
4 May 16
10-K
2015 FY
Annual report
23 Feb 16
10-Q
2015 Q3
Quarterly report
10 Nov 15
10-Q
2015 Q2
Quarterly report
5 Aug 15
10-Q
2015 Q1
Quarterly report
7 May 15
10-K
2014 FY
Annual report
26 Feb 15
10-Q
2014 Q3
Quarterly report
4 Nov 14
10-Q
2014 Q2
Quarterly report
30 Jul 14
Current reports
8-K
Entry into a Material Definitive Agreement
5 Jan 17
8-K
Departure of Directors or Certain Officers
27 Oct 16
8-K
Results of Operations and Financial Condition
19 Oct 16
8-K
St. Jude Medical and Abbott to Sell Portion of Vascular Closure and Electrophysiology Businesses to Terumo Corporation
18 Oct 16
8-K
Results of Operations and Financial Condition
20 Jul 16
8-K
Other Events
12 Jul 16
8-K
Other Events
7 Jun 16
8-K
Abbott to Acquire St. Jude Medical
28 Apr 16
8-K
Results of Operations and Financial Condition
20 Apr 16
8-K
Results of Operations and Financial Condition
27 Jan 16
Registration and prospectus
425
Business combination disclosure
7 Mar 17
425
Business combination disclosure
21 Feb 17
15-12B
Securities registration termination
17 Jan 17
S-8 POS
Registration of securities for employees (post-effective amendment)
10 Jan 17
S-8 POS
Registration of securities for employees (post-effective amendment)
10 Jan 17
S-8 POS
Registration of securities for employees (post-effective amendment)
10 Jan 17
S-8 POS
Registration of securities for employees (post-effective amendment)
10 Jan 17
S-8 POS
Registration of securities for employees (post-effective amendment)
10 Jan 17
25-NSE
Exchange delisting
4 Jan 17
POS AM
Prospectus update (post-effective amendment)
4 Jan 17
Proxies
DEFM14A
Proxy related to merger
26 Sep 16
DEF 14A
Definitive proxy
22 Mar 16
PRE 14A
Preliminary proxy
8 Mar 16
PX14A6G
Letter to shareholders
17 Apr 15
DEF 14A
Definitive proxy
25 Mar 15
PRE 14A
Preliminary proxy
2 Mar 15
DEF 14A
Definitive proxy
21 Mar 14
PRE 14A
Preliminary proxy
28 Feb 14
DEF 14A
Definitive proxy
22 Mar 13
PRE 14A
Preliminary proxy
4 Mar 13
Other
EFFECT
Notice of effectiveness
12 Jan 17
EFFECT
Notice of effectiveness
12 Jan 17
SD
Conflict minerals disclosure
31 May 16
SD
Conflict minerals disclosure
1 Jun 15
NO ACT
No action letter
3 Feb 15
UPLOAD
Letter from SEC
19 Dec 14
CORRESP
Correspondence with SEC
19 Dec 14
UPLOAD
Letter from SEC
5 Dec 14
SD
Conflict minerals disclosure
2 Jun 14
CT ORDER
Confidential treatment order
16 Jan 14
Ownership